15-Epi-LXA4 and MaR1 counter inflammation in stromal cells from patients with Achilles tendinopathy and rupture.
Dakin SG, Colas RA, Newton J, Gwilym S, Jones N, Reid HAB, Wood S, Appleton L, Wheway K, Watkins B, Dalli J, Carr AJ.
Dakin SG, et al. Among authors: wood s.
FASEB J. 2019 Jul;33(7):8043-8054. doi: 10.1096/fj.201900196R. Epub 2019 Mar 27.
FASEB J. 2019.
PMID: 30916999
Free PMC article.
In summary, we identify proresolving mediators that are active in AT and AR and propose SPMs, including 15-epi-LXA(4) or MaR1, as a potential strategy to counterregulate inflammatory processes in these cells.-Dakin, S. G., Colas, R. A., Newton, J., Gwilym, S., Jones …
In summary, we identify proresolving mediators that are active in AT and AR and propose SPMs, including 15-epi-LXA(4) or MaR1, as a potentia …